العلاج المساعد لسرطان عنق الرحم في المرحلة T1b1 أو T1b2 أو T2a1

References

Lymph node assessment should be performed as the first step of surgical management.

Adjuvant radiotherapy should be considered in the intermediate risk group (combination of risk factors at final pathology, such as tumor size, lymphovascular space involvement, and depth of stromal invasion).

When an adequate type of radical hysterectomy has been performed in intermediate risk group patients, observation is an alternative option, especially in teams experienced in this approach.

Adjuvant chemoradiotherapy is indicated in the high-risk group.

Additional brachytherapy boost as part of adjuvant conformal radiotherapy can be considered in cases with vaginal and/or parametrial positive disease.

DOI: 10.1016/j.ijgc.2025.102747